Venture Debt Explained: When It's Cheap Capital and When It's a Trap

Venture debt gets pitched as the founder-friendly alternative: capital without dilution, money that costs you interest instead of ownership. For a company with revenue, a clear milestone and a recent equity round behind it, that pitch is largely accurate and the instrument is genuinely useful.

For a company burning cash with no fundable milestone in sight, the same instrument converts a hard equity conversation into a solvency crisis, on the lender's timetable rather than yours.

The difference is not the product. It is whether you understood what you signed. This guide covers how venture debt is actually priced, what warrant coverage costs, which covenants matter, and how to tell which situation you are in.

1. What Venture Debt Is

Venture debt is term lending to venture-backed companies that would not qualify for conventional bank credit — companies with little in the way of hard assets, often unprofitable, whose creditworthiness rests largely on the quality of their equity investors and the visibility of their revenue.

Two kinds of lender operate in this market, and they behave differently:

• Banks with venture lending groups. Cheaper, more conservative, usually want your operating accounts and a broad relationship, and frequently include tighter covenants.
• Specialist debt funds. More expensive, faster, more flexible on structure and covenants, more willing to lend against recurring revenue alone.

The loan is nearly always secured by a blanket lien over the company's assets, including intellectual property in many cases, and it sits ahead of every equity holder in a liquidation. That seniority is the whole reason the interest rate is what it is, and it is the part founders most often skip past.

2. When It Actually Makes Sense

Venture debt is a timing instrument. It works when it buys you the months required to reach something that changes your valuation or your position.

Good uses:

• Extending runway to a milestone. You have twelve months of cash and need eighteen to hit the ARR figure that supports a strong Series B. Debt buys the six months, and the higher price on the equity round more than pays for the cost.
• Insurance alongside an equity round. Taking a facility at the same time as a priced round, drawn or undrawn, when your metrics are strongest and the terms are best. The cheapest time to arrange credit is when you do not need it.
• Financing specific assets. Equipment, hardware inventory, data centre capacity — assets that generate returns on a predictable schedule and can secure the loan themselves.
• Working capital against receivables. Enterprise contracts that pay in arrears create a genuine timing gap that debt is well suited to close.
• Funding an acquisition where the target's cash flow services the debt.

Bad uses:

• Funding losses with no milestone. If the next twelve months will not change how an investor values you, debt just moves the crisis and adds a creditor to it.
• Avoiding a necessary down round. A reset you delay by a year, with debt sitting senior to everyone, is materially worse than the reset you take now.
• Replacing equity you cannot raise. If sophisticated equity investors have declined, a lender who has not declined is either seeing something they do not, or pricing structure you have not read.

3. How It Is Actually Priced

The headline interest rate is the least interesting number in a venture debt term sheet. The real cost is assembled from four or five components.

Interest

Typically floating, quoted as a benchmark rate plus a spread — in recent markets, roughly six to nine hundred basis points over SOFR or a comparable index, putting all-in coupons commonly in the high single digits to mid teens depending on stage, revenue quality and lender type. Earlier-stage and non-bank lenders sit at the higher end.

Upfront or commitment fee

Commonly 0.5% to 2% of the facility, payable at closing whether or not you draw the full amount.

End-of-term or final payment fee

A lump sum, commonly 3% to 8% of the amount borrowed, due at maturity. It does not appear in the interest rate and is easy to overlook in a cash-flow model.

Prepayment penalties

Often on a declining scale — 3% in year one, 2% in year two, 1% thereafter. If you plan to repay early from a subsequent round, this matters.

Warrant coverage

This is the equity component, and it is the one founders most consistently misunderstand.

"Warrant coverage of 10% on a $5 million facility" does not mean the lender gets 10% of your company. It means the lender receives warrants to purchase $500,000 worth of stock — usually the most recent preferred series, at the price of that round. Coverage in the market commonly runs from a low single-digit percentage up to around 15% or so of the facility, with non-bank lenders and riskier credits at the higher end.

Whether that is expensive depends entirely on what happens next. If your share price triples, warrants representing $500,000 of stock at the old price are worth roughly $1.5 million, and the lender exercises. If the company struggles, they expire worthless. Warrants are cheap when things go badly and expensive when they go well — which is precisely the shape of an equity claim, and precisely why "non-dilutive" is a marketing term rather than an accurate description.

Structure

The common shape in the current market is a term loan with a 36- to 48-month life, an interest-only period of 12 to 24 months, then amortisation of principal over the remainder. The interest-only period is the part you are actually buying, because that is when the money is working for you rather than flowing back out.

4. The Covenants That Decide Your Risk

Price is negotiable and knowable. Covenants determine whether you keep control of your own timeline, and they deserve more attention than the rate.

• Material adverse change (MAC) clauses. These allow a lender to restrict further draws or, in some formulations, accelerate the loan if the business suffers a materially adverse change — typically defined broadly and assessed by the lender. A MAC clause is the single most consequential term in the document. Narrow it, tie it to objective measures, or strike it if you can.
• Minimum liquidity covenants. A requirement to hold a minimum cash balance, sometimes expressed as a multiple of monthly burn. The cruelty here is arithmetic: a covenant requiring you to hold six months of cash means a portion of what you borrowed can never actually be spent.
• Performance covenants. Minimum ARR, revenue or bookings tests, usually measured quarterly against a plan you supplied. Missing a plan you wrote optimistically is a technical default even when the business is fine.
• Investor support or "key investor" provisions. Language tying the facility to your lead investor's continued involvement. If your lead's fund life ends or they write you off, you can default without doing anything wrong.
• Deposit and banking relationship requirements. Bank lenders frequently require you to hold most or all of your operating cash with them. This concentrates counterparty risk in a way the market re-learned in 2023, and it is worth negotiating a carve-out that lets you diversify.
• Restrictions on further indebtedness, liens, dividends and asset sales. Standard, but read them — they can constrain equipment leasing, receivables financing, or an asset sale you may later need.

What happens in a default is the question to ask before signing, not after. In practice, lenders in this market usually prefer to amend, waive and reprice rather than seize a business they cannot operate. But the leverage shifts entirely, and the price of a waiver — more warrants, higher rate, tighter covenants — is set by someone who knows you have no alternative.

5. Recurring Revenue Loans and the ARR Multiple

A distinct and growing category prices off contracted recurring revenue rather than off your equity backers. Facilities are sized as a multiple of ARR or of monthly recurring revenue — commonly in the range of a third to a half of ARR for a healthy SaaS business, with the multiple driven by retention, gross margin and growth.

These structures typically feature:

• Sizing that grows automatically as revenue grows, so the facility scales with the business
• Covenants tied to retention and revenue rather than to a business plan
• Less or no warrant coverage, with a higher coupon instead

For a company with genuinely predictable subscription revenue and strong net retention, this is often better value than classic venture debt. The metrics that determine your pricing are the same ones equity investors underwrite — our guide to the metrics investors underwrite covers what "good" looks like.

It also sits alongside, rather than replacing, revenue-based financing, which shares the non-dilutive framing but repays as a percentage of revenue rather than on a fixed schedule.

6. Doing the Real Cost Calculation

Compare like with like. Take a $5 million facility over 42 months with 12 months interest-only:

• Interest at, say, 12% on a declining balance
• 1% commitment fee at closing: $50,000
• 5% final payment fee at maturity: $250,000
• 10% warrant coverage: $500,000 of stock at the last round price

Before the warrants, the effective annual cost is comfortably above the coupon — the fees alone add several points. Then value the warrants against your own expected outcome. If you genuinely believe the company will be worth three or four times more in three years, you are handing over something meaningful.

Now compare to the equity alternative. $5 million of equity at a $50 million post-money is 10% of the company, permanently. If the debt lets you reach a milestone that raises your next round price by 50%, the arithmetic usually favours the debt — and if it does not, it usually favours the equity. Model both. The answer is specific to your numbers, and the marketing on both sides is not.

Frequently Asked Questions

What do I need to qualify for venture debt?

In practice: a recent institutional equity round from investors the lender recognises, meaningful and reasonably predictable revenue, twelve months or more of cash on hand at the time of borrowing, and a clean cap table with no existing senior liens. Lenders are lending against your ability to raise the next round, so the strength of your equity syndicate is doing much of the work.

Is venture debt genuinely non-dilutive?

Not entirely. Warrant coverage is a direct equity claim, and it is the standard structure. It is less dilutive than equity for the same amount of capital, which is a real advantage, but the term "non-dilutive" is imprecise.

When is the best time to raise it?

Immediately after closing an equity round, when your cash position and metrics are strongest. Facilities arranged from a position of strength carry better pricing, looser covenants and higher amounts. A company with four months of runway approaching a lender for the first time will be quoted terms that reflect exactly that.

Can we take venture debt before a Series A?

Occasionally, in smaller amounts, from specialist lenders and usually against revenue rather than a plan. It is more expensive and the covenant package is tighter. Most seed companies are better served by extending runway operationally than by adding a senior creditor to a fragile balance sheet.

How does venture debt affect our next equity round?

New investors will look closely at the debt's seniority, maturity and covenants. Debt maturing shortly after their investment is a problem — they are effectively being asked to fund a repayment. Alignment of maturity with your funding cycle is worth negotiating up front, and it is a routine part of diligence.

The Bottom Line

Venture debt is a good instrument used at the right moment: after a strong round, against a specific milestone, in an amount you could survive repaying if the milestone slips. It is a bad instrument used to postpone a decision you have already been told to make.

Read the MAC clause. Model the fees and warrants together, not the coupon alone. And be honest about whether the money buys a milestone or just buys time.

Global Capital Network connects founders with equity investors, lenders and advisors across our network. If you are weighing debt against a round, get in touch.

This article is general information, not financial or legal advice. Credit terms vary widely by lender and situation. Have counsel and a finance advisor review any facility before you sign.